ELDN
Eledon Pharmaceuticals
$2.76
+$0.35 (+14.52%)Oct 28, 2026
Key metrics
The numbers that frame ELDN today
- Market cap
- $224.28M
- ROIC
- -83.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.35
- 52wk High
- $4.60
Growth
Revenue and earnings trend for ELDN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ELDN
Is Eledon Pharmaceuticals a good buy?
No. Eledon Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Eledon Pharmaceuticals is selling at a very high price.
What is the market capitalization of ELDN?
Eledon Pharmaceuticals's market capitalization is $224.28M.
What is the 52-week high for ELDN stock?
The 52-week high for Eledon Pharmaceuticals is $4.60. The current close of $2.76 is 40% below that high.
What is the 52-week low for ELDN stock?
The 52-week low for Eledon Pharmaceuticals is $1.35. The current close of $2.76 is 104.4% above that low.
Does ELDN stock pay dividends?
Eledon Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ELDN?
Eledon Pharmaceuticals's Debt / Equity ratio is 0.01.